RecruitingNCT06115772
Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study
Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma (PAP-OP)
Sponsor
Mayo Clinic
Enrollment
154 participants
Start Date
Nov 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
This study evaluates how often women with throat (oropharyngeal) cancer or who have a partner with oropharyngeal cancer get anogenital infections with high risk, potentially cancer-causing types of human papilloma virus (HPV).
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria5
- \* Female patients with diagnosed HPV(+)OPSCC seen at the Mayo Clinic, Rochester
- Age ≥ 18
- Female partners of Mayo Clinic patients with diagnosed HPV(+)OPSCC
- Patient has given permission to give his/her blood/saliva sample for research testing
- Ability to complete questionnaire(s) by themselves or with assistance
Exclusion Criteria4
- \* HPV(-) OPSCC
- Unable to provide informed consent
- Unwilling to attend screening visit at Mayo Clinic site, if indicated
- Unwilling/unable to complete surveys electronically
Interventions
OTHERNon-Interventional Study
Non-interventional study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06115772